<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FA3F1667-DC77-4BA3-A33F-EB2F2B0CB956"><gtr:id>FA3F1667-DC77-4BA3-A33F-EB2F2B0CB956</gtr:id><gtr:name>Medical Research Council ABPI COPD collaborative</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/FA8A4959-62A8-4182-9EFF-78C4DD583249"><gtr:id>FA8A4959-62A8-4182-9EFF-78C4DD583249</gtr:id><gtr:name>Royal Brompton &amp; Harefield NHS Fdn Trust</gtr:name><gtr:department>Respiratory Medicine</gtr:department><gtr:address><gtr:line1>Sydney Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW3 6NP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FA8A4959-62A8-4182-9EFF-78C4DD583249"><gtr:id>FA8A4959-62A8-4182-9EFF-78C4DD583249</gtr:id><gtr:name>Royal Brompton &amp; Harefield NHS Fdn Trust</gtr:name><gtr:address><gtr:line1>Sydney Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW3 6NP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FA3F1667-DC77-4BA3-A33F-EB2F2B0CB956"><gtr:id>FA3F1667-DC77-4BA3-A33F-EB2F2B0CB956</gtr:id><gtr:name>Medical Research Council ABPI COPD collaborative</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CE67AAA9-D36E-40EB-916A-E76A073C06FE"><gtr:id>CE67AAA9-D36E-40EB-916A-E76A073C06FE</gtr:id><gtr:firstName>William</gtr:firstName><gtr:surname>Man</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1002113"><gtr:id>894E79DE-EA13-4E07-BD7F-8DF015784A01</gtr:id><gtr:title>Habitual Gait Speed: A Novel Marker of Exercise Intolerance and Prognosis in COPD</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1002113</gtr:grantReference><gtr:abstractText>Chronic Obstructive Pulmonary Disease (COPD) is a very common lung disease that is usually smoking-related. People with COPD are often breathless, particularly when exerting themselves. COPD is responsible for over 25,000 deaths in the UK annually and is predicted by 2020 to be the third leading cause of death and the fifth leading cause of disability worldwide. Currently it is very difficult to objectively assess disease severity as there are many aspects to the condition that influence patients? symptoms, some of which are not focused on the lungs. Traditionally, the amount of air you can blow out in one second (FEV1) has been used to assess severity in COPD. Regulatory authorities use an improvement in FEV1 to make decisions about the approval of new drugs for COPD. However FEV1 is relevant to only some of the processes involved and hence over-reliance on this measurement would bias against treatments where the main action is outside the lungs.
In healthy older people, usual walking speed predicts loss of independence, falls, nursing home admissions, dementia and death, and is very easily measured. Walking speed may slow due to lung function decline, muscle weakness, breathlessness, the presence of multiple medical problems, poor balance, low mood and cognitive decline ? all factors seen in COPD, and it may be a simple but global marker of disease progress. The proposed research study aims to assess whether usual walking speed is a useful marker of disease severity in COPD, whether it relates to measures of exercise capacity and whether it has value in predicting hospital admission and death in patients with COPD. The research should be of interest to all health care workers involved in the care of COPD patients as it will validate a simple test that could easily be introduced into clinical practice. This research should also be of interest to the pharmaceutical industry as it could help guide the development and assessment of new and more effective medicines for COPD.</gtr:abstractText><gtr:technicalSummary>Chronic Obstructive Pulmonary Disease (COPD) is responsible for over 25,000 deaths in the UK annually and is predicted by 2020 to be the third leading cause of death and the fifth leading cause of disability worldwide. The Forced Expiratory Volume in 1 second (FEV1) is the only physiological marker acceptable to new drug regulatory authorities. However FEV1 has several limitations. COPD is a heterogeneous disease, and FEV1 is relevant to only some of the patho-physiological processes and does not address systemic manifestations such as skeletal muscle dysfunction or the influence of co-morbidities. The minimal clinically important difference for FEV1 has not been universally established, and although FEV1 correlates with mortality, this correlation is weak. In advanced disease, FEV1 has little predictive value.
In healthy older people, habitual gait speed (over 4 metres) predicts loss of independence, falls, nursing home admissions, dementia and death. Reasons for a slowing of habitual gait speed include lung function decline, skeletal muscle dysfunction secondary to sarcopaenia and de-conditioning, worsening dyspnoea, the presence of co-morbidities, poor balance, mood disorder and cognitive decline ? all factors observed in COPD. The proposed research study aims to evaluate the validity of gait speed as a marker of exercise intolerance and prognosis in COPD. Stable COPD patients will perform the 4-metre gait speed on two separate occasions a week apart to calculate inter-observer and inter-occasion reproducibility. Gait speed in COPD patients will be compared with healthy, age-matched, never smoking controls. The association between gait speed and existing measures of exercise capacity (both walking fields test and treadmill / cycle ergometry tests) will be assessed. The ability of gait speed to predict early hospital readmission in hospitalized patients at discharge following acute exacerbation of COPD will be prospectively evaluated. Furthermore, the ability of gait speed to predict mortality will be prospectively assessed in a cohort of 300 stable COPD patients followed up for a minimum of two years.
Additional validated markers are required in COPD to provide a more comprehensive and clinically meaningful assessment of patients, particularly of the extra-pulmonary manifestations of the disease. The proposed research should be of interest to clinicians involved in the care of COPD patients, and also to the pharmaceutical industry as a validated marker of functional capacity and prognosis could guide the development and assessment of new therapies for COPD, particularly those where the primary focus is not on the lung.</gtr:technicalSummary><gtr:fund><gtr:end>2014-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>249814</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council ABPI COPD collaborative</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>WP4</gtr:department><gtr:description>COPD MAP</gtr:description><gtr:id>412B0B8E-0E51-44B7-AE00-F802E0DE48F9</gtr:id><gtr:impact>Adoption of the SPPB and 4 metre gait speed as outcome measures in a longitudinal cohort study</gtr:impact><gtr:outcomeId>fA6iyrC66ny-1</gtr:outcomeId><gtr:partnerContribution>Data</gtr:partnerContribution><gtr:piContribution>Intellectual; development of SOPs for measurement of performance measures</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Health Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>NIHR CLAHRC for Northwest London</gtr:department><gtr:description>Hillingdon Pulmonary Rehabilitation Collaborative</gtr:description><gtr:id>42567960-456E-4F82-AD8D-D7C0C1373C68</gtr:id><gtr:impact>Several research abstracts accepted to national / international conferences
1 published paper in Thorax</gtr:impact><gtr:outcomeId>FVGt5vqrPsR-1</gtr:outcomeId><gtr:partnerContribution>Financial, access to PPI</gtr:partnerContribution><gtr:piContribution>Academic Clinical Lead</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>247271</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research for Patient Benefit</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>PB-PG-0213-30003</gtr:fundingRef><gtr:id>CDF27167-DD3F-4A08-A889-850B1ED402B7</gtr:id><gtr:outcomeId>545dd0ed9f5763.01862299</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14939</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Unit</gtr:department><gtr:description>NIHR Pump Priming Award</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>Royal Brompton &amp; Harefield NHS Foundation Trust</gtr:fundingOrg><gtr:id>AAB074C0-C96E-49FC-86A9-81D28784B96E</gtr:id><gtr:outcomeId>545de9234fd2f1.25825096</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>507350</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Developmental Clinical Studies</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>CB87FD15-FB9E-424C-A454-BA25A5FE86AD</gtr:id><gtr:outcomeId>pqCuw866kFh</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>239042</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Doctoral Fellowship (Primary Supervisor for Claire Nolan)</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>DRF-2014-07-089</gtr:fundingRef><gtr:id>073A4FBF-E3C3-41A8-AE39-03DD41A17AA5</gtr:id><gtr:outcomeId>545dd4ad6e1de7.53681423</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4BD2D3DA-FE24-4944-9816-F37E2B72244C</gtr:id><gtr:title>Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a4f55f33c7285d7400d331324f229b8"><gtr:id>4a4f55f33c7285d7400d331324f229b8</gtr:id><gtr:otherNames>Jones SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>doi_55f985985913be56</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B48BD27-A484-4259-932A-307D30650506</gtr:id><gtr:title>Sarcopenia definitions: where to draw the line? Response to Scarlata et al.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22bedf87b030103b10daf0b1e1966266"><gtr:id>22bedf87b030103b10daf0b1e1966266</gtr:id><gtr:otherNames>Maddocks M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>56dea1b53912a8.33854372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34188FF8-45FB-470E-8EFC-5A6BBB365096</gtr:id><gtr:title>Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89c0c491542560302154b1fa50fa51bf"><gtr:id>89c0c491542560302154b1fa50fa51bf</gtr:id><gtr:otherNames>Lewis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_15168_28_21998125</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69652D9E-ABD2-4914-A734-4761EBD0F93F</gtr:id><gtr:title>Gait speed and pedestrian crossings in COPD.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d494a7ce7e0263e1623b2cfc3a10f778"><gtr:id>d494a7ce7e0263e1623b2cfc3a10f778</gtr:id><gtr:otherNames>Nolan CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5a9c2c211d8266.57753829</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA5AE04A-0316-431B-9B78-9894C089BD15</gtr:id><gtr:title>Neuromuscular electrical stimulation to improve exercise capacity in patients with severe COPD: a randomised double-blind, placebo-controlled trial</gtr:title><gtr:parentPublicationTitle>The Lancet Respiratory Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22bedf87b030103b10daf0b1e1966266"><gtr:id>22bedf87b030103b10daf0b1e1966266</gtr:id><gtr:otherNames>Maddocks M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56dea1b69bd757.09459433</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2270867-A491-48A8-A302-A15D7BB26131</gtr:id><gtr:title>Increased skeletal muscle-specific microRNA in the blood of patients with COPD.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d31bd5c118828012549edcb29f8a90c"><gtr:id>4d31bd5c118828012549edcb29f8a90c</gtr:id><gtr:otherNames>Donaldson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_15168_28_23814167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>512B0744-B566-42B5-800F-3868A156611D</gtr:id><gtr:title>The Clinical COPD Questionnaire: response to pulmonary rehabilitation and minimal clinically important difference.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d52f1c87ffff0e8195021ade7f080332"><gtr:id>d52f1c87ffff0e8195021ade7f080332</gtr:id><gtr:otherNames>Kon SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_15168_28_24149828</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70D9EBD9-9060-4311-9080-15E375D00D16</gtr:id><gtr:title>Neural respiratory drive as a physiological biomarker to monitor change during acute exacerbations of COPD.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d7d93d1b65110273f3d999082b1c4b4"><gtr:id>1d7d93d1b65110273f3d999082b1c4b4</gtr:id><gtr:otherNames>Murphy PB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_15168_28_21597112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31FD0763-834B-427B-BE3E-AA6234785706</gtr:id><gtr:title>Response of the COPD Assessment Test to pulmonary rehabilitation in unselected chronic respiratory disease.</gtr:title><gtr:parentPublicationTitle>Respirology (Carlton, Vic.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d52f1c87ffff0e8195021ade7f080332"><gtr:id>d52f1c87ffff0e8195021ade7f080332</gtr:id><gtr:otherNames>Kon SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1323-7799</gtr:issn><gtr:outcomeId>pm_15168_28_23521698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9088180-144E-41A2-B9B3-E1EE7F7AA16A</gtr:id><gtr:title>Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f76a7f265485c2dbe40074d7948aa66"><gtr:id>6f76a7f265485c2dbe40074d7948aa66</gtr:id><gtr:otherNames>Jones S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>58a193143998c9.03987766</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB38D473-1CC8-4467-945B-45DEC37AB4BB</gtr:id><gtr:title>Muscle function in COPD: a complex interplay.</gtr:title><gtr:parentPublicationTitle>International journal of chronic obstructive pulmonary disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33807ac5f02d9e2cd85147ee2297410a"><gtr:id>33807ac5f02d9e2cd85147ee2297410a</gtr:id><gtr:otherNames>Donaldson AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1176-9106</gtr:issn><gtr:outcomeId>pm_15168_28_22973093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FD34BDF-E999-4AB4-9519-3D0E804C12E5</gtr:id><gtr:title>Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study.</gtr:title><gtr:parentPublicationTitle>Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ba2da4f6a48533954ff6ee47894d99a"><gtr:id>9ba2da4f6a48533954ff6ee47894d99a</gtr:id><gtr:otherNames>Waschki B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0954-6111</gtr:issn><gtr:outcomeId>pm_15168_28_22118987</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70034C9E-165D-4A0D-A297-B591E67C39CA</gtr:id><gtr:title>Gait speed and readmission following hospitalisation for acute exacerbations of COPD: a prospective study.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d52f1c87ffff0e8195021ade7f080332"><gtr:id>d52f1c87ffff0e8195021ade7f080332</gtr:id><gtr:otherNames>Kon SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>56dea1b619aeb6.68259812</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39C339D9-8678-49CD-8EDF-8106644A4F4A</gtr:id><gtr:title>Simple functional tests in COPD: stand up and be counted!</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22bedf87b030103b10daf0b1e1966266"><gtr:id>22bedf87b030103b10daf0b1e1966266</gtr:id><gtr:otherNames>Maddocks M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>5a9c2b4a15bd70.83113371</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEDCDA80-7BEF-430C-9B9E-51B4BEDFE766</gtr:id><gtr:title>Functionally Relevant Cut Point for Isometric Quadriceps Muscle Strength in Chronic Respiratory Disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/723db973082d727a63242bc9787c5b1f"><gtr:id>723db973082d727a63242bc9787c5b1f</gtr:id><gtr:otherNames>Canavan JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>56dea1b5bcfe56.05363714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D63A2D76-3F29-4E3C-9399-ABF1F7DE6E0F</gtr:id><gtr:title>The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d2914575cb88c9a6f61c651a7808c58"><gtr:id>8d2914575cb88c9a6f61c651a7808c58</gtr:id><gtr:otherNames>Dodd JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_15168_28_21398686</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>574B445A-AB12-4374-878D-1E35CECEFD20</gtr:id><gtr:title>Pulmonary rehabilitation in patients with MRC Dyspnoea Scale 2.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70691941c2a1e7218ce728654cfbba04"><gtr:id>70691941c2a1e7218ce728654cfbba04</gtr:id><gtr:otherNames>Man WD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_15168_28_20880873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A571845E-6636-4B6A-8891-6347C2976752</gtr:id><gtr:title>Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (Copd); implications for stratified medicine?</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4501c08079f2e4a45608eba3f24a227"><gtr:id>f4501c08079f2e4a45608eba3f24a227</gtr:id><gtr:otherNames>Natanek SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>pm_15168_28_23553751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DDEF245-D7B9-424B-903D-50903F43AB17</gtr:id><gtr:title>Continuous transcutaneous submental electrical stimulation in obstructive sleep apnea: a feasibility study.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17bbaefa754d5259d6aa7ac900d082f0"><gtr:id>17bbaefa754d5259d6aa7ac900d082f0</gtr:id><gtr:otherNames>Steier J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>pm_15168_28_21454399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCB7B0CF-82F1-49E0-81AA-7165A9429545</gtr:id><gtr:title>Minimum clinically important difference for the COPD Assessment Test: a prospective analysis</gtr:title><gtr:parentPublicationTitle>The Lancet Respiratory Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dfef56c6ddc65e5b27bbc8ed298ae8e"><gtr:id>1dfef56c6ddc65e5b27bbc8ed298ae8e</gtr:id><gtr:otherNames>Kon S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545dfbe24ebbf4.25971257</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CE4E08D-2547-47C5-90A7-B5B6BE0BDFA9</gtr:id><gtr:title>Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant?</gtr:title><gtr:parentPublicationTitle>ERJ open research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70691941c2a1e7218ce728654cfbba04"><gtr:id>70691941c2a1e7218ce728654cfbba04</gtr:id><gtr:otherNames>Man WD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2312-0541</gtr:issn><gtr:outcomeId>56dea1b5edc3a5.29855327</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>203CA6BE-BF0A-414C-A98F-A1B2ADB5FD22</gtr:id><gtr:title>Physical activity patterns and clusters in 1001 patients with COPD.</gtr:title><gtr:parentPublicationTitle>Chronic respiratory disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e4a95324c34132f8fc1e93a41761b6"><gtr:id>63e4a95324c34132f8fc1e93a41761b6</gtr:id><gtr:otherNames>Mesquita R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1479-9723</gtr:issn><gtr:outcomeId>5a9c2d2f575be8.74289312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C9FA35D-7F6B-44BF-A79A-5105AE399FFC</gtr:id><gtr:title>Neuromuscular electrical stimulation to improve exercise capacity in patients with severe COPD - Authors' reply.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22bedf87b030103b10daf0b1e1966266"><gtr:id>22bedf87b030103b10daf0b1e1966266</gtr:id><gtr:otherNames>Maddocks M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>58a1916fc1abf5.03727328</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>710FD83A-B450-4A4B-A37C-E80F2BD02BBC</gtr:id><gtr:title>The five-repetition sit-to-stand test as a functional outcome measure in COPD.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a4f55f33c7285d7400d331324f229b8"><gtr:id>4a4f55f33c7285d7400d331324f229b8</gtr:id><gtr:otherNames>Jones SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_15168_28_23783372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3ACCF37C-EEDA-4AD2-9834-9A192BC9C884</gtr:id><gtr:title>Bioelectrical impedance phase angle relates to function, disease severity and prognosis in stable chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Clinical nutrition (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22bedf87b030103b10daf0b1e1966266"><gtr:id>22bedf87b030103b10daf0b1e1966266</gtr:id><gtr:otherNames>Maddocks M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0261-5614</gtr:issn><gtr:outcomeId>56dea1b51b73e3.35029234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4334437E-FB47-4905-B77D-3C17C11556F5</gtr:id><gtr:title>Pulmonary rehabilitation and acute exacerbations of COPD.</gtr:title><gtr:parentPublicationTitle>Expert review of respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d52f1c87ffff0e8195021ade7f080332"><gtr:id>d52f1c87ffff0e8195021ade7f080332</gtr:id><gtr:otherNames>Kon SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1747-6348</gtr:issn><gtr:outcomeId>pm_15168_28_23134247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F87238A6-D6AD-4A84-8C8D-403EE9D2B448</gtr:id><gtr:title>What the 4-metre gait speed measures and why it cannot replace functional capacity tests.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d52f1c87ffff0e8195021ade7f080332"><gtr:id>d52f1c87ffff0e8195021ade7f080332</gtr:id><gtr:otherNames>Kon SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>545dfbe31f1669.75801647</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAB758A9-41BA-4211-B5E5-C5EE45E3D92B</gtr:id><gtr:title>Does pulmonary rehabilitation reduce peripheral blood pressure in patients with chronic obstructive pulmonary disease?</gtr:title><gtr:parentPublicationTitle>Chronic respiratory disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/723db973082d727a63242bc9787c5b1f"><gtr:id>723db973082d727a63242bc9787c5b1f</gtr:id><gtr:otherNames>Canavan JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1479-9723</gtr:issn><gtr:outcomeId>56dea1b59e4672.90032667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91E3C0DC-C347-433F-A990-D962668EC2C8</gtr:id><gtr:title>MuRF-1 and atrogin-1 protein expression and quadriceps fiber size and muscle mass in stable patients with COPD.</gtr:title><gtr:parentPublicationTitle>COPD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4501c08079f2e4a45608eba3f24a227"><gtr:id>f4501c08079f2e4a45608eba3f24a227</gtr:id><gtr:otherNames>Natanek SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1541-2563</gtr:issn><gtr:outcomeId>pm_15168_28_23844868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CF1E7A4-7819-4012-8BEC-DDB1E3423673</gtr:id><gtr:title>An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ef40081c388c4bd94531b42e5a83f61"><gtr:id>8ef40081c388c4bd94531b42e5a83f61</gtr:id><gtr:otherNames>Spruit MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_15168_28_24127811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40DBF064-CE2D-4FBB-B8E2-F8C089D29648</gtr:id><gtr:title>British Thoracic Society guideline on pulmonary rehabilitation in adults.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae56fa9161a4da4294a4e3cb5360f9de"><gtr:id>ae56fa9161a4da4294a4e3cb5360f9de</gtr:id><gtr:otherNames>Bolton CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_15168_28_23880483</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E655A73-D759-4B76-B5B9-CA472F341F41</gtr:id><gtr:title>Reliability and validity of 4-metre gait speed in COPD.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d52f1c87ffff0e8195021ade7f080332"><gtr:id>d52f1c87ffff0e8195021ade7f080332</gtr:id><gtr:otherNames>Kon SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pm_15168_28_23222875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>772B572B-6642-49AB-ABFA-089FDF6A3D14</gtr:id><gtr:title>ACE and response to pulmonary rehabilitation in COPD: two observational studies.</gtr:title><gtr:parentPublicationTitle>BMJ open respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d52f1c87ffff0e8195021ade7f080332"><gtr:id>d52f1c87ffff0e8195021ade7f080332</gtr:id><gtr:otherNames>Kon SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2052-4439</gtr:issn><gtr:outcomeId>5a9c2bba7fb8b9.52582932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9A423F2-55E8-4FEE-9FA1-9023E87D28D9</gtr:id><gtr:title>Children must be protected from the tobacco industry's marketing tactics.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12b1d75de5fb2fd83d1f3a206064680e"><gtr:id>12b1d75de5fb2fd83d1f3a206064680e</gtr:id><gtr:otherNames>Hopkinson N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>545dfbe29ca9b3.81402889</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00B6D654-1C8C-47B5-AD9A-ED98A627075D</gtr:id><gtr:title>Sniff nasal inspiratory pressure in patients with moderate-to-severe chronic obstructive pulmonary disease: learning effect and short-term between-session repeatability.</gtr:title><gtr:parentPublicationTitle>Respiration; international review of thoracic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/540302d1514e262bc8e01188a5e9fe17"><gtr:id>540302d1514e262bc8e01188a5e9fe17</gtr:id><gtr:otherNames>Nikoletou D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0025-7931</gtr:issn><gtr:outcomeId>545dfbe2e854a8.37495299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB46D1F7-BF60-437B-9AC8-150E2F0AA5ED</gtr:id><gtr:title>The COPD Assessment Test (CAT): short- and medium-term response to pulmonary rehabilitation.</gtr:title><gtr:parentPublicationTitle>COPD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d2914575cb88c9a6f61c651a7808c58"><gtr:id>8d2914575cb88c9a6f61c651a7808c58</gtr:id><gtr:otherNames>Dodd JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1541-2563</gtr:issn><gtr:outcomeId>pm_15168_28_22497561</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A913881-43E3-45D0-AE92-B59F1C36583E</gtr:id><gtr:title>Angiotensin-Converting Enzyme Inhibition as an Adjunct to Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a2ac06cc6e2f2a639238f8192881b8a"><gtr:id>9a2ac06cc6e2f2a639238f8192881b8a</gtr:id><gtr:otherNames>Curtis KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>58a18f96be2cc3.45643941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B61D44C-8A28-4338-8CFE-E84B35081E1E</gtr:id><gtr:title>The 4-metre gait speed in COPD: responsiveness and minimal clinically important difference.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d52f1c87ffff0e8195021ade7f080332"><gtr:id>d52f1c87ffff0e8195021ade7f080332</gtr:id><gtr:otherNames>Kon SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pm_15168_28_24177002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>900A82ED-E6E3-452B-A1D2-61BF707D8881</gtr:id><gtr:title>Klotho and smoking--An interplay influencing the skeletal muscle function deficits that occur in COPD.</gtr:title><gtr:parentPublicationTitle>Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18761a3ef7b702f36ea4f2f2c24dd4f2"><gtr:id>18761a3ef7b702f36ea4f2f2c24dd4f2</gtr:id><gtr:otherNames>Patel MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0954-6111</gtr:issn><gtr:outcomeId>58a1909ca58622.68655481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>986E899B-257B-464A-B88E-8512E93CA7E7</gtr:id><gtr:title>Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22bedf87b030103b10daf0b1e1966266"><gtr:id>22bedf87b030103b10daf0b1e1966266</gtr:id><gtr:otherNames>Maddocks M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>58a190f01f35d2.57591424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>162E1607-B5A0-4B98-9F27-E7E62C6AF883</gtr:id><gtr:title>Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: referrals, uptake and adherence.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a4f55f33c7285d7400d331324f229b8"><gtr:id>4a4f55f33c7285d7400d331324f229b8</gtr:id><gtr:otherNames>Jones SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_15168_28_23945168</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A6B968E-AD75-43A3-AD40-D1FF82AF1913</gtr:id><gtr:title>Singing classes for chronic obstructive pulmonary disease: a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>BMC pulmonary medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19900fb1aa458edf738ba6eb3fa65640"><gtr:id>19900fb1aa458edf738ba6eb3fa65640</gtr:id><gtr:otherNames>Lord VM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2466</gtr:issn><gtr:outcomeId>pm_15168_28_23145504</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1076F417-7855-4B98-85EC-FC4C8C58957B</gtr:id><gtr:title>Yin Yang 1 expression and localisation in quadriceps muscle in COPD.</gtr:title><gtr:parentPublicationTitle>Archivos de bronconeumologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4501c08079f2e4a45608eba3f24a227"><gtr:id>f4501c08079f2e4a45608eba3f24a227</gtr:id><gtr:otherNames>Natanek SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0300-2896</gtr:issn><gtr:outcomeId>pm_15168_28_21565439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B90BDF96-70C6-43A8-8841-F4C87364AC07</gtr:id><gtr:title>Socioeconomic deprivation and the outcome of pulmonary rehabilitation in England and Wales.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3552568001d14568f5c8ac4a08b4b36"><gtr:id>d3552568001d14568f5c8ac4a08b4b36</gtr:id><gtr:otherNames>Steiner MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>58a1948cba2c01.97127011</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6265D247-B811-432C-BDF3-068CF23DAC36</gtr:id><gtr:title>Stanford Seven-Day Physical Activity Recall questionnaire in COPD.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c7ee2b5c83333e1201e0531aaa9e2f"><gtr:id>69c7ee2b5c83333e1201e0531aaa9e2f</gtr:id><gtr:otherNames>Garfield BE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pm_15168_28_22183486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5B20793-EAA7-4E90-9116-96E0F4C085E7</gtr:id><gtr:title>Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.</gtr:title><gtr:parentPublicationTitle>Journal of the American Medical Directors Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c328c08c104d291ec03127462ef9c2e5"><gtr:id>c328c08c104d291ec03127462ef9c2e5</gtr:id><gtr:otherNames>Smid DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1525-8610</gtr:issn><gtr:outcomeId>5a9c3017baa5a7.64336554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C0C6116-B38B-4AD8-A816-72A7E2E76A91</gtr:id><gtr:title>Clinical COPD Questionnaire in patients with chronic respiratory disease.</gtr:title><gtr:parentPublicationTitle>Respirology (Carlton, Vic.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/723db973082d727a63242bc9787c5b1f"><gtr:id>723db973082d727a63242bc9787c5b1f</gtr:id><gtr:otherNames>Canavan JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1323-7799</gtr:issn><gtr:outcomeId>545dfbe275ae68.20157481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>062029C1-23A6-4FE2-8BAE-EDAC63BA759C</gtr:id><gtr:title>Rehabilitation after an exacerbation of chronic respiratory disease.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70691941c2a1e7218ce728654cfbba04"><gtr:id>70691941c2a1e7218ce728654cfbba04</gtr:id><gtr:otherNames>Man WD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>545dfbe2c1c3a4.21032430</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>007371B2-F54C-4DFF-BEA9-6BFA5E65F911</gtr:id><gtr:title>Phenotypic characteristics associated with reduced short physical performance battery score in COPD.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18761a3ef7b702f36ea4f2f2c24dd4f2"><gtr:id>18761a3ef7b702f36ea4f2f2c24dd4f2</gtr:id><gtr:otherNames>Patel MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>545dfbe34588e4.47784786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D41F5821-8CF1-4B7C-8F0B-0356E63B014B</gtr:id><gtr:title>The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d494a7ce7e0263e1623b2cfc3a10f778"><gtr:id>d494a7ce7e0263e1623b2cfc3a10f778</gtr:id><gtr:otherNames>Nolan CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>585d69d1bd9645.18946414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CBBDD8C-D50B-4E67-9081-28AE0370D92A</gtr:id><gtr:title>Phenotypic characteristics associated with slow gait speed in idiopathic pulmonary fibrosis.</gtr:title><gtr:parentPublicationTitle>Respirology (Carlton, Vic.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d494a7ce7e0263e1623b2cfc3a10f778"><gtr:id>d494a7ce7e0263e1623b2cfc3a10f778</gtr:id><gtr:otherNames>Nolan CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1323-7799</gtr:issn><gtr:outcomeId>5a9c2f34796b62.91598971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>503E971D-E52D-46A5-AC7A-46F3AD405C8D</gtr:id><gtr:title>Palliative care and management of troublesome symptoms for people with chronic obstructive pulmonary disease</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22bedf87b030103b10daf0b1e1966266"><gtr:id>22bedf87b030103b10daf0b1e1966266</gtr:id><gtr:otherNames>Maddocks M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a9c2e23c54d84.65294958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A0B95B0-52F2-4D28-A3A5-20979D3060AA</gtr:id><gtr:title>Muscle mass and strength in obstructive lung disease: a smoking gun?</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d52f1c87ffff0e8195021ade7f080332"><gtr:id>d52f1c87ffff0e8195021ade7f080332</gtr:id><gtr:otherNames>Kon SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_15168_28_21813620</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1002113</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>